| Date Filed | Type | Description |
| 08/17/2023 |
4
| Racine Jean-Olivier (Chief Technology Officer) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 752 shares
@ $15.1, valued at
$11.4k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
4
| Racine Jean-Olivier (Chief Technology Officer) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 735 shares
@ $19.91, valued at
$14.6k
|
|
| 01/30/2023 |
4
| Racine Jean-Olivier (Chief Technology Officer) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 2,066 shares
@ $27.92, valued at
$57.7k
|
|
| 01/09/2023 |
4
| Racine Jean-Olivier (Chief Technology Officer) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 38,834 shares
@ $0
Granted 2,184 shares
@ $0 |
|
| 11/17/2022 |
4
| Racine Jean-Olivier (Chief Technology Officer) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 292 shares
@ $19.29, valued at
$5.6k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Racine Jean-Olivier (Chief Technology Officer) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 21,489 shares
@ $0
Granted 1,209 shares
@ $0 |
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 06/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |